chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Nasal congestion, Nausea, Pain, Pyrexia
Clinical narrative: Body pain; Blood in ears; Shortness of breath; Congested; Flu-like symptoms; Sore and red at injection site; Sore and red at injection site; Headaches in temples and across head; Low grade fever; Really tired; Throwing up; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body pain), EAR HAEMORRHAGE (Blood in ears), DYSPNOEA (Shortness of breath), NASAL CONGESTION (Congested) and INFLUENZA LIKE ILLNESS (Flu-like symptoms) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039V20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Body pain), EAR HAEMORRHAGE (Blood in ears), DYSPNOEA (Shortness of breath), NASAL CONGESTION (Congested), INFLUENZA LIKE ILLNESS (Flu-like symptoms), VACCINATION SITE PAIN (Sore and red at injection site), VACCINATION SITE ERYTHEMA (Sore and red at injection site), HEADACHE (Headaches in temples and across head), PYREXIA (Low grade fever), FATIGUE (Really tired), VOMITING (Throwing up) and NAUSEA (Nauseous). The patient was treated with ACETYLSALICYLIC ACID (ALKA-SELTZER) at an unspecified dose and frequency. At the time of the report, PAIN (Body pain), EAR HAEMORRHAGE (Blood in ears), DYSPNOEA (Shortness of breath), NASAL CONGESTION (Congested), INFLUENZA LIKE ILLNESS (Flu-like symptoms), VACCINATION SITE PAIN (Sore and red at injection site), VACCINATION SITE ERYTHEMA (Sore and red at injection site), HEADACHE (Headaches in temples and across head), PYREXIA (Low grade fever), FATIGUE (Really tired), VOMITING (Throwing up) and NAUSEA (Nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: low (Low) Low.         No concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.    Action taken with mRNA-1273 in response to the events was not applicable.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vomiting
Clinical narrative: Body pain; Blood in ears; Shortness of breath; Congested; Flu-like symptoms; Sore and red at injection site; Sore and red at injection site; Headaches in temples and across head; Low grade fever; Really tired; Throwing up; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body pain), EAR HAEMORRHAGE (Blood in ears), DYSPNOEA (Shortness of breath), NASAL CONGESTION (Congested) and INFLUENZA LIKE ILLNESS (Flu-like symptoms) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039V20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Body pain), EAR HAEMORRHAGE (Blood in ears), DYSPNOEA (Shortness of breath), NASAL CONGESTION (Congested), INFLUENZA LIKE ILLNESS (Flu-like symptoms), VACCINATION SITE PAIN (Sore and red at injection site), VACCINATION SITE ERYTHEMA (Sore and red at injection site), HEADACHE (Headaches in temples and across head), PYREXIA (Low grade fever), FATIGUE (Really tired), VOMITING (Throwing up) and NAUSEA (Nauseous). The patient was treated with ACETYLSALICYLIC ACID (ALKA-SELTZER) at an unspecified dose and frequency. At the time of the report, PAIN (Body pain), EAR HAEMORRHAGE (Blood in ears), DYSPNOEA (Shortness of breath), NASAL CONGESTION (Congested), INFLUENZA LIKE ILLNESS (Flu-like symptoms), VACCINATION SITE PAIN (Sore and red at injection site), VACCINATION SITE ERYTHEMA (Sore and red at injection site), HEADACHE (Headaches in temples and across head), PYREXIA (Low grade fever), FATIGUE (Really tired), VOMITING (Throwing up) and NAUSEA (Nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: low (Low) Low.         No concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.    Action taken with mRNA-1273 in response to the events was not applicable.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Skin disorder, Swelling
Clinical narrative: Sore; Red; 2.5 inches round circle; Swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Sore), ERYTHEMA (Red), SKIN DISORDER (2.5 inches round circle) and SWELLING (Swollen) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PAIN (Sore), ERYTHEMA (Red), SKIN DISORDER (2.5 inches round circle) and SWELLING (Swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Sore), ERYTHEMA (Red), SKIN DISORDER (2.5 inches round circle) and SWELLING (Swollen) outcome was unknown.            Concomitant product use was not provided by the reporter.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye swelling, Fatigue, Pain, Pain in extremity
Clinical narrative: Sore arm; Swollen arm; Red arm; Itchy arm; Left eye is swollen; Fatigue; A little pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (A little pain), PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (Red arm) and PRURITUS (Itchy arm) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN (A little pain) and FATIGUE (Fatigue). On 14-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (Red arm), PRURITUS (Itchy arm) and EYE SWELLING (Left eye is swollen). At the time of the report, PAIN (A little pain), PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (Red arm), PRURITUS (Itchy arm), EYE SWELLING (Left eye is swollen) and FATIGUE (Fatigue) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided.  No treatment was reported for the events.  Patient stated that she took second dose on an unknown date.   This case was linked to MOD-2021-114193 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Updated all events outcome from unknown to recovered on an unknown date and provided the second dose details.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus
Clinical narrative: Sore arm; Swollen arm; Red arm; Itchy arm; Left eye is swollen; Fatigue; A little pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (A little pain), PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (Red arm) and PRURITUS (Itchy arm) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN (A little pain) and FATIGUE (Fatigue). On 14-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (Red arm), PRURITUS (Itchy arm) and EYE SWELLING (Left eye is swollen). At the time of the report, PAIN (A little pain), PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (Red arm), PRURITUS (Itchy arm), EYE SWELLING (Left eye is swollen) and FATIGUE (Fatigue) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided.  No treatment was reported for the events.  Patient stated that she took second dose on an unknown date.   This case was linked to MOD-2021-114193 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Updated all events outcome from unknown to recovered on an unknown date and provided the second dose details.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Injection site pruritus, Injection site rash, Lip erythema
Clinical narrative: Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw; Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw; itchy at the injection site; rash at injection site; burning at the injection site; Muscle ache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw), LIP ERYTHEMA (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw), INJECTION SITE PRURITUS (itchy at the injection site), INJECTION SITE RASH (rash at injection site) and INJECTION SITE PAIN (burning at the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ESCITALOPRAM OXALATE (AVESTALO) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced MYALGIA (Muscle ache) and FATIGUE (fatigue). On 12-Mar-2021, the patient experienced LIP SWELLING (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw), INJECTION SITE PRURITUS (itchy at the injection site), INJECTION SITE RASH (rash at injection site) and INJECTION SITE PAIN (burning at the injection site). 12-Mar-2021, the patient experienced LIP ERYTHEMA (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. On 12-Mar-2021, MYALGIA (Muscle ache) had resolved. At the time of the report, LIP SWELLING (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw) and LIP ERYTHEMA (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw) was resolving, INJECTION SITE PRURITUS (itchy at the injection site) and INJECTION SITE PAIN (burning at the injection site) outcome was unknown and INJECTION SITE RASH (rash at injection site) and FATIGUE (fatigue) had resolved.            Concomitant medications were not provided.  Action taken with mRNA-1273 in response to the event was not applicable   This case was linked to MOD-2021-079367 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Provided the Email address.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Myalgia
Clinical narrative: Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw; Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw; itchy at the injection site; rash at injection site; burning at the injection site; Muscle ache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw), LIP ERYTHEMA (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw), INJECTION SITE PRURITUS (itchy at the injection site), INJECTION SITE RASH (rash at injection site) and INJECTION SITE PAIN (burning at the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ESCITALOPRAM OXALATE (AVESTALO) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced MYALGIA (Muscle ache) and FATIGUE (fatigue). On 12-Mar-2021, the patient experienced LIP SWELLING (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw), INJECTION SITE PRURITUS (itchy at the injection site), INJECTION SITE RASH (rash at injection site) and INJECTION SITE PAIN (burning at the injection site). 12-Mar-2021, the patient experienced LIP ERYTHEMA (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. On 12-Mar-2021, MYALGIA (Muscle ache) had resolved. At the time of the report, LIP SWELLING (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw) and LIP ERYTHEMA (Scar tissue from 14 years ago inside lower lip swelled up, was bright red and raw) was resolving, INJECTION SITE PRURITUS (itchy at the injection site) and INJECTION SITE PAIN (burning at the injection site) outcome was unknown and INJECTION SITE RASH (rash at injection site) and FATIGUE (fatigue) had resolved.            Concomitant medications were not provided.  Action taken with mRNA-1273 in response to the event was not applicable   This case was linked to MOD-2021-079367 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Provided the Email address.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Redness on site of vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness on site of vaccination) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Heart disease, unspecified.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness on site of vaccination). At the time of the report, VACCINATION SITE ERYTHEMA (Redness on site of vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications includes unspecified high blood pressure medications and heart medications.  No treatment information was provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Plicated tongue
Clinical narrative: tongue is cracking and sore; Face red and hot; This spontaneous case was reported by a consumer and describes the occurrence of PLICATED TONGUE (tongue is cracking and sore) and FLUSHING (Face red and hot) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced PLICATED TONGUE (tongue is cracking and sore) and FLUSHING (Face red and hot). On 14-Mar-2021, FLUSHING (Face red and hot) outcome was unknown. At the time of the report, PLICATED TONGUE (tongue is cracking and sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  No treatment medications were provided
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Dizziness, Fatigue
Clinical narrative: diarrhea; light headed; nausea; fatigue; fever of 99 F; body aches; chills; dull headache; Sore arm; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (diarrhea), DIZZINESS (light headed), PAIN IN EXTREMITY (Sore arm), PYREXIA (fever of 99 F) and MYALGIA (body aches) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (dull headache). On 10-Mar-2021, the patient experienced CHILLS (chills). On 12-Mar-2021, the patient experienced PYREXIA (fever of 99 F), MYALGIA (body aches) and FATIGUE (fatigue). On 13-Mar-2021, the patient experienced DIARRHOEA (diarrhea), DIZZINESS (light headed) and NAUSEA (nausea). At the time of the report, DIARRHOEA (diarrhea), DIZZINESS (light headed), PAIN IN EXTREMITY (Sore arm), PYREXIA (fever of 99 F), MYALGIA (body aches), HEADACHE (dull headache), CHILLS (chills), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99 (Inconclusive) 99 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.   This case was linked to MOD-2021-045281.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: diarrhea; light headed; nausea; fatigue; fever of 99 F; body aches; chills; dull headache; Sore arm; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (diarrhea), DIZZINESS (light headed), PAIN IN EXTREMITY (Sore arm), PYREXIA (fever of 99 F) and MYALGIA (body aches) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (dull headache). On 10-Mar-2021, the patient experienced CHILLS (chills). On 12-Mar-2021, the patient experienced PYREXIA (fever of 99 F), MYALGIA (body aches) and FATIGUE (fatigue). On 13-Mar-2021, the patient experienced DIARRHOEA (diarrhea), DIZZINESS (light headed) and NAUSEA (nausea). At the time of the report, DIARRHOEA (diarrhea), DIZZINESS (light headed), PAIN IN EXTREMITY (Sore arm), PYREXIA (fever of 99 F), MYALGIA (body aches), HEADACHE (dull headache), CHILLS (chills), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99 (Inconclusive) 99 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.   This case was linked to MOD-2021-045281.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Got sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got sick) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Got sick). At the time of the report, ILLNESS (Got sick) outcome was unknown.            No concomitant medications were provided.  No treatment medications were provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Vaccination site mass
Clinical narrative: Still has a little bump from the first dose at the vaccination site; A little diarrhea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Still has a little bump from the first dose at the vaccination site), DIARRHOEA (A little diarrhea) and FATIGUE (Fatigue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concomitant products included LIRAGLUTIDE (VICTOZA), METFORMIN, LOSARTAN, CLOPIDOGREL and ROSUVASTATIN for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Still has a little bump from the first dose at the vaccination site), DIARRHOEA (A little diarrhea) and FATIGUE (Fatigue). At the time of the report, VACCINATION SITE MASS (Still has a little bump from the first dose at the vaccination site) had not resolved and DIARRHOEA (A little diarrhea) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: some of the vaccine leaked out and syringe part; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (some of the vaccine leaked out and syringe part) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (some of the vaccine leaked out and syringe part). At the time of the report, UNDERDOSE (some of the vaccine leaked out and syringe part) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided by the reporter no treatment information reported by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow up received on 15-jun-2021, contains No New information
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain lower, Asthenia, Dizziness, Fatigue, Feeling hot
Clinical narrative: feels weak; felt warm; he could not stay awake; fatigue and tired; pain in his lower abdomen; Could not sleep last night because the pain was so bad; little dizzy; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN LOWER (pain in his lower abdomen), ASTHENIA (feels weak), FEELING HOT (felt warm), DIZZINESS (little dizzy) and SOMNOLENCE (he could not stay awake) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 5AW1-U56-MH22) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.     On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced DIZZINESS (little dizzy). On 14-Mar-2021, the patient experienced ABDOMINAL PAIN LOWER (pain in his lower abdomen) and INSOMNIA (Could not sleep last night because the pain was so bad). On 15-Mar-2021, the patient experienced ASTHENIA (feels weak), FEELING HOT (felt warm), SOMNOLENCE (he could not stay awake) and FATIGUE (fatigue and tired). At the time of the report, ABDOMINAL PAIN LOWER (pain in his lower abdomen), ASTHENIA (feels weak), FEELING HOT (felt warm), DIZZINESS (little dizzy), SOMNOLENCE (he could not stay awake) and FATIGUE (fatigue and tired) had not resolved and INSOMNIA (Could not sleep last night because the pain was so bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Reportedly, the patient could not sleep because the pain in his lower abdomen was very bad.
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Somnolence
Clinical narrative: feels weak; felt warm; he could not stay awake; fatigue and tired; pain in his lower abdomen; Could not sleep last night because the pain was so bad; little dizzy; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN LOWER (pain in his lower abdomen), ASTHENIA (feels weak), FEELING HOT (felt warm), DIZZINESS (little dizzy) and SOMNOLENCE (he could not stay awake) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 5AW1-U56-MH22) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.     On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced DIZZINESS (little dizzy). On 14-Mar-2021, the patient experienced ABDOMINAL PAIN LOWER (pain in his lower abdomen) and INSOMNIA (Could not sleep last night because the pain was so bad). On 15-Mar-2021, the patient experienced ASTHENIA (feels weak), FEELING HOT (felt warm), SOMNOLENCE (he could not stay awake) and FATIGUE (fatigue and tired). At the time of the report, ABDOMINAL PAIN LOWER (pain in his lower abdomen), ASTHENIA (feels weak), FEELING HOT (felt warm), DIZZINESS (little dizzy), SOMNOLENCE (he could not stay awake) and FATIGUE (fatigue and tired) had not resolved and INSOMNIA (Could not sleep last night because the pain was so bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Reportedly, the patient could not sleep because the pain in his lower abdomen was very bad.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Rhinorrhoea
Clinical narrative: Runny nose; Fever; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose), PYREXIA (Fever) and FATIGUE (exhaustion) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced RHINORRHOEA (Runny nose), PYREXIA (Fever) and FATIGUE (exhaustion). At the time of the report, RHINORRHOEA (Runny nose), PYREXIA (Fever) and FATIGUE (exhaustion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain in extremity
Clinical narrative: Sore arms; Headaches; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arms), HEADACHE (Headaches) and MYALGIA (Muscle aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arms), HEADACHE (Headaches) and MYALGIA (Muscle aches). At the time of the report, PAIN IN EXTREMITY (Sore arms), HEADACHE (Headaches) and MYALGIA (Muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage
Clinical narrative: minor bleeding after the administration of her 2nd dose; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE HAEMORRHAGE (minor bleeding after the administration of her 2nd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE HAEMORRHAGE (minor bleeding after the administration of her 2nd dose). At the time of the report, VACCINATION SITE HAEMORRHAGE (minor bleeding after the administration of her 2nd dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up information received on 24-MAY-2021, contains no new information.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Diarrhoea, Dyspnoea, Headache
Clinical narrative: Felling really bad; has been in bed for 2 days, only goes to the bathroom and straight to bed again.; Usually has difficulty breathing but once she takes her inhalators she can breath better again, this is not happening now, the difficulty is ongoing/felt like an elephant foot on my chest, when breathing; Diarrhea; stomach sick, cannot eat; Feels very very weak; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felling really bad), IMPAIRED WORK ABILITY (has been in bed for 2 days, only goes to the bathroom and straight to bed again.), DYSPNOEA (Usually has difficulty breathing but once she takes her inhalators she can breath better again, this is not happening now, the difficulty is ongoing/felt like an elephant foot on my chest, when breathing), DIARRHOEA (Diarrhea) and ABDOMINAL DISCOMFORT (stomach sick, cannot eat) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD (She has COPD and usually has difficulty breathing but once she takes her inhalators she can breath better again). Concomitant products included LOSARTAN and LORAZEPAM for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced MALAISE (Felling really bad), IMPAIRED WORK ABILITY (has been in bed for 2 days, only goes to the bathroom and straight to bed again.), DYSPNOEA (Usually has difficulty breathing but once she takes her inhalators she can breath better again, this is not happening now, the difficulty is ongoing/felt like an elephant foot on my chest, when breathing), DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (stomach sick, cannot eat), ASTHENIA (Feels very very weak) and HEADACHE (Headache). At the time of the report, MALAISE (Felling really bad), IMPAIRED WORK ABILITY (has been in bed for 2 days, only goes to the bathroom and straight to bed again.), DYSPNOEA (Usually has difficulty breathing but once she takes her inhalators she can breath better again, this is not happening now, the difficulty is ongoing/felt like an elephant foot on my chest, when breathing), DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (stomach sick, cannot eat), ASTHENIA (Feels very very weak) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant medications included unspecified pain medications (as needed, not daily) and inhalers (unspecified). The patient received treatment with "peptize".
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Malaise
Clinical narrative: Felling really bad; has been in bed for 2 days, only goes to the bathroom and straight to bed again.; Usually has difficulty breathing but once she takes her inhalators she can breath better again, this is not happening now, the difficulty is ongoing/felt like an elephant foot on my chest, when breathing; Diarrhea; stomach sick, cannot eat; Feels very very weak; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felling really bad), IMPAIRED WORK ABILITY (has been in bed for 2 days, only goes to the bathroom and straight to bed again.), DYSPNOEA (Usually has difficulty breathing but once she takes her inhalators she can breath better again, this is not happening now, the difficulty is ongoing/felt like an elephant foot on my chest, when breathing), DIARRHOEA (Diarrhea) and ABDOMINAL DISCOMFORT (stomach sick, cannot eat) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD (She has COPD and usually has difficulty breathing but once she takes her inhalators she can breath better again). Concomitant products included LOSARTAN and LORAZEPAM for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced MALAISE (Felling really bad), IMPAIRED WORK ABILITY (has been in bed for 2 days, only goes to the bathroom and straight to bed again.), DYSPNOEA (Usually has difficulty breathing but once she takes her inhalators she can breath better again, this is not happening now, the difficulty is ongoing/felt like an elephant foot on my chest, when breathing), DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (stomach sick, cannot eat), ASTHENIA (Feels very very weak) and HEADACHE (Headache). At the time of the report, MALAISE (Felling really bad), IMPAIRED WORK ABILITY (has been in bed for 2 days, only goes to the bathroom and straight to bed again.), DYSPNOEA (Usually has difficulty breathing but once she takes her inhalators she can breath better again, this is not happening now, the difficulty is ongoing/felt like an elephant foot on my chest, when breathing), DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (stomach sick, cannot eat), ASTHENIA (Feels very very weak) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant medications included unspecified pain medications (as needed, not daily) and inhalers (unspecified). The patient received treatment with "peptize".
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Rash
Clinical narrative: sore headache; rush all over her body, is bad in her ankles; really sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (really sore arm), RASH (rush all over her body, is bad in her ankles) and HEADACHE (sore headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (really sore arm). On 11-Mar-2021, the patient experienced RASH (rush all over her body, is bad in her ankles). On an unknown date, the patient experienced HEADACHE (sore headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (really sore arm), RASH (rush all over her body, is bad in her ankles) and HEADACHE (sore headache) outcome was unknown.            Concomitant medications included blood thinner medications.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Lymphadenopathy
Clinical narrative: Lump in her armpit (injection side), it's about 2 inches large and hot; Lump in her armpit (injection side), it's about 2 inches large and hot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Lump in her armpit (injection side), it's about 2 inches large and hot) and LYMPHADENOPATHY (Lump in her armpit (injection side), it's about 2 inches large and hot) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer in 1988. Concomitant products included ATORVASTATIN CALCIUM (LIPTOR [ATORVASTATIN CALCIUM]), VITAMIN A [RETINOL], ACETYLSALICYLIC ACID (BABY ASPIRIN) and CLONAZEPAM for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced FEELING HOT (Lump in her armpit (injection side), it's about 2 inches large and hot) and LYMPHADENOPATHY (Lump in her armpit (injection side), it's about 2 inches large and hot). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK, prn. At the time of the report, FEELING HOT (Lump in her armpit (injection side), it's about 2 inches large and hot) and LYMPHADENOPATHY (Lump in her armpit (injection side), it's about 2 inches large and hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant products used included Hydrops, Systemin and Sorect.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Cough, Dyspnoea, Fatigue
Clinical narrative: cough; mild shortness of breath; Fever; Chills; Nausea; Fatigue/tiredness; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), DYSPNOEA (mild shortness of breath), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included INSULIN and PANTOPRAZOLE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced COUGH (cough), DYSPNOEA (mild shortness of breath), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue/tiredness) and ARTHRALGIA (joint pain). At the time of the report, COUGH (cough), DYSPNOEA (mild shortness of breath), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue/tiredness) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: cough; mild shortness of breath; Fever; Chills; Nausea; Fatigue/tiredness; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), DYSPNOEA (mild shortness of breath), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included INSULIN and PANTOPRAZOLE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced COUGH (cough), DYSPNOEA (mild shortness of breath), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue/tiredness) and ARTHRALGIA (joint pain). At the time of the report, COUGH (cough), DYSPNOEA (mild shortness of breath), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue/tiredness) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Nausea
Clinical narrative: Nausea; fatigue; This spontaneous case was reported by a nurse and describes the occurrence of NAUSEA (Nausea) and FATIGUE (fatigue) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history was reported.     On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021 at 11:00 AM, the patient experienced NAUSEA (Nausea) and FATIGUE (fatigue). At the time of the report, NAUSEA (Nausea) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Initiative, email from reporter asking for patient identifiers.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Myalgia, Tachycardia
Clinical narrative: tachycardia; less dizziness; very little overall muscle pain; This spontaneous case was reported by a physician and describes the occurrence of TACHYCARDIA (tachycardia), DIZZINESS (less dizziness) and MYALGIA (very little overall muscle pain) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013m20a and 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy, Lymphoma (non-Hodgkin's) (Recurring) since 2011 and Lymphoma (non-Hodgkin's) (First diagnosis) since 2004. Concomitant products included ASA, FISH OIL, MINERALS NOS, VITAMINS NOS (MULTIVITAMIN AND MINERAL SUPPLEMENT), schizandra and UBIDECARENONE (Q10) for an unknown indication.   On 16-Jan-2021 at 8:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced MYALGIA (very little overall muscle pain). On an unknown date, the patient experienced TACHYCARDIA (tachycardia) and DIZZINESS (less dizziness). At the time of the report, TACHYCARDIA (tachycardia), DIZZINESS (less dizziness) and MYALGIA (very little overall muscle pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient states that his heart rate was up 150 bpm, saturation was 99 to 97%. Patient did not seek medical attention as she being a doctor herself. She has taken lots of water and electrolytes.  Treatment information not provided.   This case was linked to MOD-2021-006185, MOD-2021-006185 (Patient Link).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: COVID Positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID Positive) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID Positive). At the time of the report, SARS-COV-2 TEST POSITIVE (COVID Positive) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Dizziness; Nausea/vomiting; Nausea/vomiting; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), NAUSEA (Nausea/vomiting) and VOMITING (Nausea/vomiting) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021 at 2:15 AM, the patient experienced DIZZINESS (Dizziness), NAUSEA (Nausea/vomiting) and VOMITING (Nausea/vomiting). At the time of the report, DIZZINESS (Dizziness), NAUSEA (Nausea/vomiting) and VOMITING (Nausea/vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatments and concomitant medications were not provided.     Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Non Significant FU, Additional information included Anatomical location,Patient initials, Date of birth, event start date and time updated.